PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTION BETWEEN DWP16001, A NOVEL SODIUM GLUCOSE COTRANSPORTER 2 INHIBITOR, AND METFORMIN IN HEALTHY SUBJECTS.

被引：0
作者：
Chung, W. [1 ]
Lee, S. [1 ]
Na, J. [1 ]
Lee, S. [1 ]
Lee, S. [1 ]
Cho, J. [1 ]
Jang, I. [1 ]
机构：
[1] Seoul Natl Univ, Seoul, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2021年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-039
引用
收藏
页码：S39 / S40
页数：2
相关论文
共 50 条
  • [1] Pharmacokinetic and pharmacodynamic interaction between DWP16001, an sodium-glucose cotransporter 2 inhibitor and metformin in healthy subjects
    Kim, Byungwook
    Huh, Ki Young
    Hwang, Jun Gi
    Nah, JaeJin
    Huh, Wan
    Cho, Jae Min
    Jang, In-Jin
    Yu, Kyung-Sang
    Kim, Yun
    Lee, SeungHwan
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (04) : 1462 - 1470
  • [2] Pharmacokinetic and pharmacodynamic interaction of DWP16001, a sodium-glucose cotransporter 2 inhibitor, with gemigliptin and metformin in healthy adults
    Jeong, Sae Im
    Kim, Yun
    Nah, Jae Jin
    Huh, Wan
    Jang, In-Jin
    Hwang, Jun Gi
    Lee, SeungHwan
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (06) : 1780 - 1788
  • [3] Pharmacokinetic and pharmacodynamic interaction of DWP16001, a sodium-glucose cotransporter-2 inhibitor, with phentermine in healthy subjects
    Yoon, Sukyong
    Park, Min Soo
    Jin, Byung Hak
    Shin, Hyobin
    Na, Jaejin
    Huh, Wan
    Kim, Choon Ok
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2023, : 479 - 485
  • [4] DRUG- DRUG INTERACTION BETWEEN THE NOVEL SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITOR, DWP16001, WITH GEMIGLIPTIN AND METFORMIN IN HEALTHY SUBJECTS.
    Chung, W.
    Jeong, S.
    Lee, S.
    Won, H.
    Huh, W.
    Han, J.
    Yu, K.
    Lee, S.
    Jang, I.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S50 - S50
  • [5] Dose-dependent glucosuria of DWP16001, a novel selective sodium-glucose cotransporter-2 inhibitor, in healthy subjects
    Hwang, Jun Gi
    Lee, SeungHwan
    Huh, Wan
    Han, Jumi
    Oh, Jaeseong
    Jang, In-Jin
    Yu, Kyung-Sang
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (09) : 4100 - 4110
  • [6] In Vitro Metabolism of DWP16001, a Novel Sodium-Glucose Cotransporter 2 Inhibitor, in Human and Animal Hepatocytes
    Kim, Ju-Hyun
    Kim, Dong Kyun
    Choi, Won-Gu
    Ji, Hye-Young
    Choi, Ji-Soo
    Song, Im-Sook
    Lee, Sangkyu
    Lee, Hye Suk
    PHARMACEUTICS, 2020, 12 (09) : 1 - 17
  • [7] Comparative Pharmacokinetics and Pharmacodynamics of a Novel Sodium-Glucose Cotransporter 2 Inhibitor, DWP16001, with Dapagliflozin and Ipragliflozin
    Choi, Min-Koo
    Nam, So Jeong
    Ji, Hye-Young
    Park, Mi Jie
    Choi, Ji-Soo
    Song, Im-Sook
    PHARMACEUTICS, 2020, 12 (03)
  • [8] Effect of the sodium-glucose cotransporter-2 inhibitor, DWP16001, as an add-on therapy to insulin for diabetic dogs: A pilot study
    An, Ju-Hyun
    Choi, Han-Sol
    Choi, Ji-Soo
    Lim, Hyun-Woo
    Huh, Wan
    Oh, Ye-In
    Park, Joon Seok
    Han, Jumi
    Lim, Soo
    Lim, Chae-Young
    Kim, Tae-Hee
    Moon, Jae-Bong
    Youn, Hwa-Young
    VETERINARY MEDICINE AND SCIENCE, 2024, 10 (03)
  • [9] Dose-dependent glucosuria of DWP16001: a novel selective SGLT2 inhibitor in healthy male Korean subjects
    Hwang, J.
    Lee, S. -W.
    Lee, S.
    Yu, K. -S.
    Han, J.
    Huh, W.
    Kim, H.
    DIABETOLOGIA, 2019, 62 : S358 - S358
  • [10] Pharmacokinetic and Pharmacodynamic Interaction Between Gemigliptin and Metformin in Healthy Subjects
    Shin, Dongseong
    Cho, Young Min
    Lee, SeungHwan
    Lim, Kyoung Soo
    Kim, Jeong-Ae
    Ahn, Ji-Yung
    Cho, Joo-Youn
    Lee, Howard
    Jang, In-Jin
    Yu, Kyung-Sang
    CLINICAL DRUG INVESTIGATION, 2014, 34 (06) : 383 - 393
12345